This paper introduces a new integrated approach to measure unified efficiency of the healthcare systems. Health centers as an important part of the healthcare systems are considered for evaluation. For this purpose, we define two categories of inputs to measure performance of health centers based on medical human resources and characteristics of spatial information by using geographic information system (GIS). Catching the balance in the spatial distribution of populations and services is one of the main problems in health centers evaluation. On the other hand, data envelopment analysis (DEA) is widely applied for measuring efficiency of the healthcare systems. But, the conventional DEA models may fail to integrated several categories of measures. In this paper, DEA and bargaining game model are integrated for evaluation of health centers. In other words, two categories of measures are used to measure unified efficiency for each health center in the competitive environment. Two models according to constant return to scale (CRS) and variable return to scale (VRS) assumptions are developed. The case study of health centers under supervising of Tehran university of medical sciences (TMUS) is presented to show the abilities of the proposed approach.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10916-012-9853-z | DOI Listing |
Int J Epidemiol
December 2024
Urban Health Collaborative, Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA.
Am J Respir Cell Mol Biol
January 2025
Rostock University Medical Center, Institute of Medical Microbiology, Virology and Hygiene, Rostock, Germany.
(Group A Streptococcus, GAS) is a human pathogen that causes local and systemic infections of the skin and mucous membranes. However, GAS is also found asymptomatically in the nasopharynx of infants. GAS infections, including pharyngitis and invasive pneumosepsis, pose significant public health concerns.
View Article and Find Full Text PDFObjective: Elevated blood pressure (BP), even at prehypertensive levels, increases cardiovascular disease risk among people with HIV (PWH); yet international guidelines in low-income countries recommend treatment initiation at BP at least 140/90 mmHg. We determined the efficacy, feasibility, and acceptability of treating prehypertension in PWH in Haiti.
Design: An unblinded randomized clinical trial (enrolled April 2021-March 2022) with 12-month follow-up.
Ann Intern Med
January 2025
Center for Healthcare Delivery Sciences, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (R.J.D., N.K.C., N.H., J.C.L.).
Background: The evidence informing the harms of gabapentin use are at risk of bias from comparing users with nonusers.
Objective: To describe the risk for fall-related outcomes in older adults starting treatment with gabapentin versus duloxetine.
Design: New user, active comparator study using a target trial emulation framework.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!